United States · FDA National Drug Code directory
minocycline hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-534_d984bc89-8412-45fd-ba75-e707bc53ae3d
- Product NDC
- 68382-534
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- minocycline hydrochloride
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250612
- Source listing expiry
- 20261231
Source-listed ingredients
- MINOCYCLINE HYDROCHLORIDE — 115 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-534-01) · 68382-534-01
- 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-534-05) · 68382-534-05
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-534-06) · 68382-534-06
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-534-10) · 68382-534-10
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-534-16) · 68382-534-16
- 10 BLISTER PACK in 1 CARTON (68382-534-30) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 68382-534-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →